Aspira is Transforming Women’s Health with an Innovative Solution
Offering Protein Biomarker and Genetic Testing options to provide greater physician insights, facilitate early detection and optimize treatment plans.
- Over 10 years of experience in Ovarian Cancer Risk assessment and Pelvic mass management
- Cutting edge bioinformatics for analysis and data management
- Experienced in quality-focused patient care
- Laboratory Research focused on innovative discovery
Want to Learn More About Our Products?
OVA1plus Protein Biomarkers
Ovarian Cancer Risk Assessment for women with adnexal masses
Aspira GenetiX Testing
Hereditary Breast and Ovarian Cancer Genetic Testing, Carrier Screening for Autosomal Recessive and X-Linked Recessive Disorders